Mobi-C Cervical Disc Prosthesis
Highridge Medical, LLC · Decision date Mar 23, 2026
What did the FDA decide?
FDA records P110002/S038 as a supplement to PMA P110002, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Mar 23, 2026.
FDA approval order statement
addition of a new raw material supplier (IKH) for titanium powder used in the plasma spray coating of Mobi-C inferior and superior endplates, and qualification of a back-up final cleaning line (HAMO 210 #LA2165) for cleaning of Mobi-C inserts and jaws performed at the same Viant facility
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Orthopedic
- Decision date
- Mar 23, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
Regulatory record facts
- Identifier
- P110002/S038
- Regulatory pathway
- PMA supplement
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- Decision code
- OK30
- Decision date
- Mar 23, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, intervertebral disc.
- Applicant
- Highridge Medical, LLC
- Product code
- MJO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P110002. Subsequent supplements may change the device or its indications.
FDA decision timeline
P110002 · Original PMA
MOBI-C CERVICAL DISC PROSTHESIS (ONE-LEVEL INDICATION)
P110002/S037 · Related supplement
LDR Spine Mobi-C Cervical Disc Prosthesis
P110002/S038 received
Application receipt date recorded by FDA.
P110002/S038 · FDA decision
30-Day Notice
P110002/S040 · Related supplement
Mobi-C Cervical Disc Prosthesis for use at One Level
Timeline entries are records held by MedtechLedger for P110002. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P110002
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Highridge Medical, LLC | PMA approval | Aug 7, 2013 | FDA | |
LDR Spine Mobi-C Cervical Disc ProsthesisP110002/S037 | Highridge Medical, LLC | PMA supplement | Oct 29, 2025 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA |
Explore the linked device profile
Other records with product code MJO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BAGUERAC Cervical Disc ProsthesisP250042/S002 | Spineart USA, Inc. | PMA supplement | Sep 22, 2026 | FDA |
Synergy DiscP250028/S003 | Synergy Spine Solutions, Inc. | PMA supplement | Sep 17, 2026 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
prodisc C NovaP070001/S031 | Centinel Spine, LLC | PMA supplement | Sep 9, 2026 | FDA |
BAGUERAC Cervical Disc ProsthesisP250042/S001 | Spineart USA, Inc. | PMA supplement | Aug 27, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Highridge Medical, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 10225 Westmoor Dr., Westminister, CO, 80021
Sources and methodology
- Original FDA record: P110002/S038
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 21, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



